Key Market Indicators
Serbia's antibiotics export is projected to decline significantly over the next five years. By 2028, the export value is expected to drop to roughly $470,000, down from approximately $890,000 in 2023. This represents an annual decrease of 10.3% in compound annual growth rate (CAGR). Since 2011, Serbian antibiotic supply has consistently fallen by 5% year on year. On the import front, Serbia's antibiotics market is also set for a considerable reduction. Imports are forecasted to shrink to about $2.1 million by 2028, down from $4.3 million in 2023. This marks an annual decline of 11.8% in CAGR. Since 2010, Serbian demand for antibiotics has decreased by 7% annually. These troubling trends reflect broader challenges facing Serbia's pharmaceutical sector, both in terms of production and consumption.
